{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:36:59Z","timestamp":1774571819705,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) has been identified increasingly frequently in recent years. However, this rare MOG antibody disease may coexist with anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDARe), in an overlap syndrome with unknown clinical features and prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We report a new case of this overlap syndrome and present a systematic review of similar cases in the literature to provide information on the clinical presentation, MRI features, EGG abnormalities, treatment, and prognosis of patients with this rare syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 12 patients were analyzed in the study. The most common clinical manifestations of FLAMES overlaid with anti-NMDARe were epilepsy (12\/12), headache (11\/12), and fever (10\/12). Increases in intracranial pressure (median: 262.5 mmH<jats:sub>2<\/jats:sub>O, range: 150\u2013380 mmH<jats:sub>2<\/jats:sub>O), cerebrospinal fluid (CSF) leukocyte count (median: 128\u00d710<jats:sup>6<\/jats:sup>\/L, range: 1-610\u00d710<jats:sup>6<\/jats:sup>\/L), and protein level (median: 0.48 g\/L) were also observed. The median CSF anti-NMDAR antibody titer was 1:10 (1:1\u20131:32), while the median serum MOG antibody titer was 1:32 (1:10\u20131:1024). Seven cases exhibited unilateral cortical FLAIR hyperintensity, and five cases (42%) had bilateral cortical FLAIR hyperintensity, including four cases involving the bilateral medial frontal lobes. Of the 12 patients, five showed lesions at other sites (e.g., the brainstem, corpus callosum, or frontal orbital gyrus) before or after the development of cortical encephalitis. EEG showed slow waves in four cases, spike\u2013slow waves in two cases, an epileptiform pattern in one case, and normal waves in two cases. The median number of relapses was two. Over a mean follow-up period of 18.5 months, only one patient experienced residual visual impairment, while the remaining 11 patients had good prognoses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>FLAMES alone is difficult to distinguish from overlap syndrome based on clinical features. However, FLAMES with bilateral medial frontal lobe involvement suggests the presence of the overlap syndrome.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1149987","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:41:37Z","timestamp":1681710097000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures overlaying anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Jia-Xin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao-Miao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Juan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1044642","article-title":"Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum","volume":"13","author":"Budhram","year":"2022","journal-title":"Front Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2010.06598.x","article-title":"The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier","volume":"113","author":"Reijerkerk","year":"2010","journal-title":"J Neurochem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009239","article-title":"Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies","volume":"94","author":"Martinez-Hernandez","year":"2020","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.09.023","article-title":"Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies","volume":"18","author":"Zhou","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001194","article-title":"[A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis]","volume":"58","author":"Nagata","year":"2018","journal-title":"Rinsho Shinkeigaku"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.08.002","article-title":"Repeated anti-N-methyl-D-aspartate receptor encephalitis coexisting with anti-myelin oligodendrocyte glycoprotein antibody-associated diseases: A case report","volume":"35","author":"Aoe","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100338","DOI":"10.1016\/j.ebr.2019.100338","article-title":"Overlapping demyelinating syndrome and anti-N-methyl-D-aspartate receptor encephalitis with seizures","volume":"12","author":"Taraschenko","year":"2019","journal-title":"Epilepsy Behav Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021238","article-title":"Anti-NMDA receptor encephalitis concomitant with myelin oligodendrocyte glycoprotein antibody diseases: A retrospective observational study","volume":"99","author":"Du","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24117","article-title":"Overlapping demyelinating syndromes and anti\u2013N-Methyl-D-Aspartate receptor encephalitis","volume":"75","author":"Titulaer","year":"2014","journal-title":"Ann Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"102611","DOI":"10.1016\/j.msard.2020.102611","article-title":"Anti-NMDAR encephalitis may develop concurrently with anti-MOG antibody-associated bilateral medial frontal cerebral cortical encephalitis and relapse with elevated CSF IL-6 and CXCL13","volume":"47","author":"Fujimori","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919125","article-title":"Case report: Overlapping syndrome mimicking infectious meningoencephalitis in a patient with coexistent MOG, NMDAR, mGluR5 antibody positivity","volume":"13","author":"Fu","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.799454","article-title":"Case report: Overlapping syndrome of anti-NMDAR encephalitis and MOG inflammatory demyelinating disease in a patient with human herpesviruses 7 infection","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"103727","DOI":"10.1016\/j.msard.2022.103727","article-title":"Clinical analysis of adult MOG antibody-associated cortical encephalitis","volume":"60","author":"Yao","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.639265","article-title":"Case report: Anti-NMDAR encephalitis with anti-MOG CNS demyelination after recurrent CNS demyelination","volume":"12","author":"Ren","year":"2021","journal-title":"Front Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol: Neuroimmunol Neuroinflamm"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-315094","article-title":"Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies","volume":"88","author":"Fujimori","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15684","article-title":"Non-ADEM encephalitis in patients with myelin oligodendrocyte glycoprotein antibodies: a systematic review","author":"Vega","year":"2023","journal-title":"Eur J Neurol"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1038\/nature04302","article-title":"NMDA receptors are expressed in oligodendrocytes and activated in ischaemia","volume":"438","author":"Karadottir","year":"2005","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000445","article-title":"Postviral autoimmune encephalitis: manifestations in children and adults","volume":"30","author":"Pruss","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.01.007","article-title":"Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis","volume":"20","author":"Fan","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.msard.2020.102468","article-title":"Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate","volume":"46","author":"Cherian","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2022.04.001","article-title":"Electroclinical features of seizures in myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: A case report and literature review","volume":"98","author":"Tokumoto","year":"2022","journal-title":"Seizure"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.03.019","article-title":"An unusual case of anti-MOG CNS demyelination with concomitant mild anti-NMDAR encephalitis","volume":"320","author":"Zhou","year":"2018","journal-title":"J Neuroimmunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1149987\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:41:39Z","timestamp":1681710099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1149987\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2023.1149987"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1149987","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1149987"}}